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A key question for understanding the mecha-
nism of autoimmune disease is how hazardous 
self-reactive T cells are produced by the thy-
mus, become activated in the periphery, and 
diff  erentiate to eff  ector T cells that destroy the 
target organ, or how genetic and environmental 
factors contribute to this process. Autoimmune 
disease due to a defect of a single gene is instru-
mental in addressing these questions, especially 
when the disease is clinically and immunologi-
cally similar to common autoimmune diseases 
that are supposed to be multifactorial (1).
The SKG strain of mice, a mutant on the 
BALB/c background, spontaneously develops 
T cell–mediated autoimmune arthritis, which 
clinically and immunologically resembles rheu-
matoid arthritis (RA) in humans (2, 3). The 
strain harbors a recessive mutation of the gene 
encoding an SH2 domain of ζ-associated pro-
tein 70 (ZAP-70), a key signaling molecule 
in T cells (4). Impaired signal transduction 
through SKG ZAP-70 results in thymic posi-
tive selection and failure in negative selection 
of highly self-reactive T cells that include po-
tentially arthritogenic CD4+ T cells (2). SKG 
mice spontaneously develop severe arthritis in 
a conventional environment, whereas they fail 
to develop the disease in microbially clean 
environments, for example, under a specifi  c 
pathogen-free (SPF) condition (5). Yet arthritis 
can be elicited in an SPF environment through 
antigen-nonspecifi  c activation of innate immu-
nity, for example, by injection of zymosan, a 
crude fungal extract containing β-glucans, or 
purifi  ed β-glucans such as laminarin (5). The 
disease can also be triggered by provoking 
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homeostatic proliferation of self-reactive T cells (5). The strain 
is therefore a suitable model for elucidating how self-reactive 
T cells develop and diff   erentiate to arthritogenic eff  ector 
T cells, and how autoimmune arthritis can be triggered by en-
vironmental insults in the presence of genetic predisposition.
In this report, we show that autoimmune arthritis in SKG 
mice is highly dependent on the development of CD4+ 
T cells secreting IL-17, a proinfl  ammatory cytokine capable of 
recruiting and activating neutrophils and other infl  ammatory 
cells (6). We have analyzed how self-reactive CD4+ T cells 
produced by the thymus diff  erentiate to arthritogenic Th17 
cells through internally forming a particular cytokine milieu 
by interacting with APCs, and how they become activated to 
cause autoimmune arthritis.
RESULTS AND DISCUSSION
Spontaneous development of arthritogenic Th17 cells 
in SKG mice and its augmentation by zymosan 
or 𝗃-glucan administration
In vitro PMA/ionomycin treatment for 5 h, which activates 
a signal transduction step down-stream of ZAP-70 and there-
fore equally activates SKG and BALB/c T cells, revealed that 
a signifi  cant fraction of LN CD4+ T cells from nonarthritic 
SKG mice in an SPF environment were producing IL-17A 
(hereafter IL-17), whereas SKG or BALB/c CD4-SP thymo-
cytes or BALB/c CD4+ T cells were not (Fig. 1 A and Fig. 
S1, which is available at http://www.jem.org/cgi/content/
full/jem.20062259/DC1). Such IL-17–producing SKG CD4+ 
T cells also produced at a single cell level TNF-α and 
IL-2, but not IFN-γ, IL-4, or IL-10, a profi  le distinct from 
Th1 or Th2 cells and similar to that of Th17 cells (Fig. 1 A; 
references 7–9). CD4+ T cells freshly prepared from nonar-
thritic SKG mice also actively transcribed IL-17 and IL-23R 
mRNA (Fig. 1 B). In arthritic SKG mice raised in a conven-
tional environment, arthritic joints actively transcribed IL-17 
mRNA, whereas nonarthritic ones did not (Fig. 1 C). Cor-
respondingly, CD4+ T cells producing IL-17 and not IFN-γ 
infi  ltrated into the arthritic joints as revealed by intracellular 
cytokine staining of CD4+ T cells dispersed from the in-
fl  amed synovial tissue (Fig. 1 D; reference 5). Both IL-17–
  intact (IL-17+/+) and –defi  cient (IL-17−/−) SKG mice, prepared 
by genetic backcrossing from IL-17−/− BALB/c mice (10), 
did not develop arthritis under our SPF conditions, although 
the former harbored IL-17–producing CD4+ T cells (Fig. 
1 A). When CD4+ T cell suspensions prepared from each strain 
were transferred to RAG2−/− BALB/c mice, however, all 
the recipients of IL-17+/+ CD4+ T cells developed arthritis 
with high arthritis scores within 3 mo, whereas none of those 
transferred with IL-17−/− CD4+ T cells showed joint swell-
ing (Fig. 1 E). The former exhibited histologically severe 
  synovitis and destruction of cartilage and bone (Fig. 1 F). 
Furthermore, injection of zymosan or laminarin, which can 
trigger arthritis in SPF SKG mice (5), increased three- to 
fourfold the number of IL-17+ cells in SKG, but not in 
BALB/c mice (Fig. 1 G). Thus, naive CD4+ T cells in SKG 
mice are spontaneously activated and diff  erentiate to Th17 
cells, which are indispensable for the development of this auto-
immune disease. Such potentially arthritogenic Th17 cells 
appear to persist in the periphery and begin mediating arthritis 
Figure 1.  Spontaneous development of arthritogenic Th17 cells in 
SKG mice. (A) HSA− CD4-SP thymocytes or LN CD4+ T cells were stained 
for intracellular cytokines. (B) Quantitative RT-PCR for IL-17 and IL-23R 
mRNA in CD4+ T cells. Data are shown as the mean ± SD of three inde-
pendent experiments. (C) Total RNA extracted from the ankle joints of 
individual mice with or without arthritis was subjected to quantitative 
RT-PCR for IL-17 mRNA. (D) CD4+ T cells infi  ltrating arthritic joints were 
stained as in A. (E) 106 CD4+ T cells from IL-17+/+ or IL-17−/− SKG mice 
were transferred to RAG2−/− mice. Incidence and severity of arthritis 
were scored every week as described previously (reference 2). Vertical bars 
represent the means ± SEM. (F) Histology of an ankle joint of a RAG2−/− 
mouse transferred with IL-17−/− or IL-17+/+ SKG CD4+ T cells (bar, 1 mm; 
hematoxylin and eosin staining). (G) Mice received a single i.p. injection of 
2 mg zymosan or 30 mg laminarin. LN CD4+ T cells were stained for intra-
cellular IL-17 and IFN-γ 2 wk later. Results in A, D, and G represent three 
to fi  ve independent experiments.JEM VOL. 204, January 22, 2007  43
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when stimulated, for example, by their transfer to a T cell–
defi  cient environment and resulting homeostatic prolifera-
tion (see also below), or by exposure to microbial products, 
such as fungal or bacterial β-glucans, which further facilitate 
expansion/diff  erentiation of Th17 cells, presumably by stim-
ulating APCs (5). In addition, complete inhibition of disease 
development by the defi  ciency of IL-17 alone indicates that 
IL-17F, another IL-17 family member secreted by CD4+ 
T cells and having a similar function (6), is dispensable for 
the disease.
In vivo differentiation of self-reactive T cells to Th17 cells 
in SKG mice
SKG mice harbored phenotypically activated CD4+ T cells 
whether they had developed arthritis or not, whereas SKG 
CD4+CD8− (CD4–single-positive [SP]) thymocytes, CD8-
SP thymocytes, and CD8+ T cells were of a naive surface 
phenotype and similar to their BALB/c counterparts (Fig. 2 A 
and not depicted). Regardless of hyporesponsiveness to 
TCR stimulation because of the ZAP-70 anomaly (2), SKG 
CD4+ T cells were twice as proliferative as BALB/c CD4+ 
T cells in the physiological state, as shown with in vivo BrdU 
incorporation (Fig. 2 B). Divided cells constituted 50% of 
SKG CD4+ T cells within 3 wk compared with 20% of 
BALB/c CD4+ T cells (Fig. 2 C). Thymectomy in adults did 
not aff  ect the proliferation, indicating that the proliferating 
T cells are not recent thymic emigrants, but peripheral T cells 
(Fig. 2 C). When heat-stable antigen–negative (HSA−) CD4-
SP mature thymocytes or splenic CD4+ T cells labeled by 
CFSE were transferred to RAG2−/− mice, transferred SKG 
CD4+ T cells or thymocytes gave rise to higher percentages 
of CFSE-diluted (i.e., proliferating) cells, in particular highly 
proliferating CFSElow cells, than their BALB/c counterparts 
(Fig. 2 D). Notably, BALB/c CD4+ T cells, which scarcely 
produced IL-17 before transfer (Fig. 1 A), also diff  erentiated 
spontaneously to Th17 cells to a similar extent as SKG CD4+ 
Figure 2.  T cell self-reactivity and in vivo spontaneous differen-
tiation of Th17 cells. (A) CD4-SP thymocytes and LN CD4+ T cells from 
6-wk-old BALB/c or SKG mice were stained with designated mAbs. 
(B) Mice were given BrdU for 9 d, and LN CD4+ T cells were stained with 
anti-BrdU. (C) Mice that had been thymectomized at 4 wk of age were 
administered with BrdU for the indicated days from 6 wk of age, and 
percentages of BrdU-stained cells among CD4+ T cells are shown. ATx, 
adult thymectomy; STx, sham thymectomy. (D and E) HSA− CD4-SP thy-
mocytes or CD4+ T cells (3 × 106) were labeled by CFSE and transferred to 
RAG2−/− mice. 5 d later, recipient splenic CD4+ T cells were assessed for 
CFSE profi  le and intracellular IL-17 and IFN-γ. Results in A, B, D, and E 
represent three to fi  ve independent experiments.
Figure 3.  T cell self-reactivity and in vitro cytokine production. 
(A) HSA− CD4-SP thymocytes or CD4+ T cells were cultured with autologous 
APCs in the presence or absence of anti–class II MHC blocking mAb. 
  Proliferation was measured by [3H]thymidine incorporation. Vertical bars 
signify SD. (B) Culture supernatants in the AMLR shown in A were col-
lected and assessed for IL-6, TNF-α, and IL-17 production. (C) CD4+ T cells 
from IL-6−/−, TNF-α−/−, IL-17−/−, or cytokine-intact SKG mice were cul-
tured with cytokine-defi  cient or -intact APCs, and culture supernatants 
were collected on day 7 for cytokine assessment as in B. (D) Anti-CD40L 
or anti-OX40L blocking mAb (100 μg/ml) was added to the culture, and 
proliferation or cytokine production was assessed as shown in A and B. 
Results in A–D represent three independent experiments.44  TH17 CELLS IN SPONTANEOUS AUTOIMMUNE ARTHRITIS | Hirota et al.
T cells (Fig. 2 E). The diff  erentiation required cell division: 
BALB/c CD4+ T cells produced IL-17 or IFN-γ only after 
several cell divisions.
Collectively, these results indicate that SKG thymus pro-
duces highly self-reactive T cells, which are constantly acti-
vated in the periphery, proliferate, and diff  erentiate to Th17 
cells (Fig. 1 A). Both SKG and BALB/c T cells can equally 
diff  erentiate to Th17 as well as Th1 cells after homeostatic 
proliferation; however, BALB/c T cells fail to produce 
  arthritis in this setting, presumably because of their lack or 
insuffi   ciency of relevant arthritogenic self-reactivity.
In vitro self-reactivity of SKG CD4+ T cells 
and their stimulation of APCs to secrete cytokines
Supporting the in vivo high proliferative activity of SKG 
T cells, SKG CD4-SP mature thymocytes and CD4+ T cells 
exhibited vigorous in vitro proliferative responses to autologous 
APCs, and the responses were completely inhibited by adding 
anti–class II MHC mAb to the culture (Fig. 3 A). They pro-
duced large amounts of IL-6 and TNF-α in this autologous 
MLR (AMLR), whereas only peripheral CD4+ T cells pro-
duced a detectable amount of IL-17 (Fig. 3 B). Use of cyto-
kine-defi  cient BALB/c APCs or SKG CD4+ T cells in various 
combinations revealed that IL-6 was predominantly derived 
from APCs, TNF-α from both SKG CD4+ T cells and BALB/c 
APCs, and IL-17 solely from SKG CD4+ T cells (Fig. 3 C). 
Moreover, blockade of CD40L substantially reduced cell pro-
liferation and production of IL-6, TNF-α, and IL-17. OX40L 
blockade exerted similar eff   ects, although to lesser extents 
(Fig. 3 D). Collectively, SKG CD4+ thymocytes and T cells 
strongly respond to class II MHC/self-peptide complexes ex-
pressed by autologous APCs, and reciprocally stimulate APCs 
to secrete IL-6 and TNF-α. In addition, CD40–CD40L and 
to a lesser extent OX40–OX40L interactions contribute to 
this T cell–APC interaction and, consequently, to the forma-
tion of IL-17 by T cells, IL-6 by APCs, and TNF-α by both.
Critical role of IL-6 for the development of arthritogenic 
Th17 cells in SKG mice
We then examined with cytokine-defi  cient SKG mice how 
a cytokine milieu aff  ects in vivo spontaneous development 
of Th17 cells in SKG mice. IL-6–defi  cient SKG mice were 
completely devoid of IL-17+ CD4+ T cells, whereas TNF-α–, 
IL-1–, or IFN-γ–defi  cient SKG mice harbored equivalent 
numbers of IL-17+ CD4+ T cells as cytokine-intact SKG 
mice (Fig. 4 A). When IL-6−/− SKG or BALB/c CD4+ 
T cells devoid of Th17 cells were transferred to IL-6+/+ 
RAG2−/− mice, they gave rise to Th17 cells within a week 
after homeostatic proliferation (Fig. 4 B). This in vivo Th17 
diff   erentiation did not happen in the transfer of SKG or 
BALB/c IL-6−/− T cells to IL-6−/− RAG2−/− mice and 
  occurred to a small degree when either the T cell donors or 
the recipients were IL-6 defi  cient. Of note in these cell trans-
fers is that the degree of Th17 development from SKG CD4+ 
T cells was well correlated with the incidence and severity of 
arthritides in the recipients (Fig. 4 C).
Collectively, IL-6 produced by either T cells or non–
T cells is indispensable for in vivo development and/or 
expansion of Th17 cells and consequently the occurrence 
of auto  immune arthritis. IL-6 produced by either cell source 
is synergistic in promoting this T cell diff  erentiation  and 
  autoimmune development. Although IL-23 is capable of am-
plifying and sustaining Th17 cells (11), it is unable to replace 
the function of IL-6 to induce Th17 cells. In addition, not 
only SKG CD4+ T cells but also CD4+ T cells in normal 
BALB/c mice are similarly dependent on IL-6 in this setting 
of Th17 diff  erentiation.
Spontaneous development of arthritis in IFN-𝗄–defi  cient 
SKG mice due to enhanced Th17 differentiation
Notably, IFN-γ–defi  cient SKG mice spontaneously devel-
oped histologically severe arthritides even under SPF con-
ditions (Fig. 5, A and B). After homeostatic proliferation in 
Figure 4.  The role of IL-6 for the development of arthritogenic 
Th17 cells in SKG mice. (A) LN CD4+ T cells from cytokine-defi  cient SKG 
mice were stained for intracellular IL-17 and IFN-γ. (B) 2 × 106 CD4+ 
T cells from the indicated donor mice were transferred to IL-6−/− or intact 
RAG2−/− mice. Intracellular IL-17 and IFN-γ in recipient splenic CD4+ 
T cells were stained on day 7. (C) 106 CD4+ T cells from IL-6+/+ or IL-6−/− 
SKG mice were transferred to IL-6+/+ or IL-6−/− RAG2−/− mice. Incidence 
and severity of arthritis in four groups of mice were assessed every week. 
Vertical bars represent the means ± SEM of scores. In comparison of 
four groups (●, IL-6+/+→IL-6+/+RAG−/−; ■, IL-6−/−→IL-6+/+RAG−/−; 
▲, IL-6+/+→IL-6−/−RAG−/−; ○, IL-6−/−→IL-6−/−RAG−/−), statistically signi-
fi  cant (P < 0.05) differences in scores are: ● versus ■, 5–12 wk; ● versus 
▲, 5–12 wk; ● versus ○, 5–12 wk; ■ versus ○, 9–12 wk; ▲ versus ○, 
9–12 wk; ■ versus ▲, at 12 wk. Results in A and B represent three inde-
pendent experiments.JEM VOL. 204, January 22, 2007  45
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RAG2−/− mice, CD4+ T cells from IFN-γ−/− SKG mice 
diff  erentiated more effi   ciently to Th17 cells than IFN-γ+/+ 
SKG CD4+ T cells, suggesting that IFN-γ may suppress the 
diff  erentiation/expansion of Th17 cells (Fig. 5 C). To exam-
ine the relationship between IL-6 and IFN-γ in this Th17 
diff  erentiation, we blocked IL-6R by administering anti–IL-
6R mAb to RAG2−/− mice transferred with CD4+ T cells 
from wild-type, IFN-γ−/−, or IL-17−/− mice (Fig. 5 C). The 
blockade inhibited the diff   erentiation/expansion of both 
normal and IFN-γ−/− CD4+ T cells to Th17 cells, indicating 
that IL-6 can directly promote Th17 diff  erentiation, and not 
via the reduction of IFN-γ. In addition, IL-17−/− CD4+ 
T cells more effi   ciently diff  erentiated/expanded to IFN-γ–
producing cells than wild-type CD4+ T cells, and IL-6R 
blockade facilitated this diff   erentiation/expansion of both 
wild-type and IL-17−/− CD4+ T cells.
Thus, these fi  ndings, together with effi   cient development 
of IFN-γ–producing cells under IL-6 defi  ciency (Fig. 4 B) 
and the known capacity of IL-6 to directly inhibit Th1 cell 
diff  erentiation (12), indicate that IL-6 and IL-17 suppress 
Th1 diff  erentiation and IFN-γ production, and, reciprocally, 
IFN-γ suppresses Th17 diff  erentiation. This in vivo cross-
regulation between IL-17/IL-6 and IFN-γ plays a critical 
role in the maintenance of immunological self-tolerance, as 
IFN-γ defi  ciency can break self-tolerance in SPF SKG mice 
by facilitating the diff  erentiation/expansion of arthritogenic 
Th17 cells.
In vivo contribution of TGF-𝗃 and natural regulatory 
T (T reg) cells to the development of Th17 cells
There is recent in vitro evidence that IL-6 and TGF-β to-
gether promote the diff  erentiation of naive CD4+ T cells 
to Th17 cells and IFN-γ inhibits it (8, 9, 13–15). In our 
in vivo induction of Th17 cells from BALB/c or SKG CD4+ 
T cells via homeostatic proliferation, i.v. administration of 
neutralizing anti–TGF-β mAb at in vivo–saturating doses re-
duced the number of IL-17+ cells to a half of control mice 
without reduction of IFN-γ+ cells (Fig. 5 D and Fig. S2, 
which is available at http://www.jem.org/cgi/content/full/
jem.20062259/DC1). CD25+CD4+ natural T reg cells were 
suggested as a possible source of TGF-β (13). Th17 cells, 
however, equally developed from CD25+ cell-depleted or 
nondepleted BALB/c T cells after homeostatic proliferation 
(Fig. 5 E; reference 16). Furthermore, T reg cell depletion 
exacerbated SKG arthritis, whereas inoculation of natural 
T reg cells from normal BALB/c mice suppressed disease de-
velopment (unpublished data). Thus, TGF-β physiologically 
produced by various tissues may promote in vivo Th17 dif-
ferentiation in the presence of IL-6. How natural T reg cells 
are involved in this process remains to be determined.
The SKG thymus produces self-reactive T cells with a 
variety of antigen specifi  cities as illustrated by polyclonal ac-
tivation of self-reactive thymocytes and T cells in AMLR. 
Some self-reactive T cells may recognize joint self-antigens as 
indicated by their helper function for the development of 
IgG autoantibodies against type II collagen and other constit-
uents of the joint (2). Others may stimulate APCs to secrete 
cytokines, especially IL-6, and, together with T cell–derived 
IL-6, form a cytokine milieu for the preferential diff  erentia-
tion of joint-specifi  c self-reactive T cells to Th17 cells. Other 
cytokines, including IFN-γ, TGF-β, TNF-α, IL-1, and IL-23, 
may also positively or negatively contribute to forming 
the cytokine milieu for Th17 development (3, 13, 17, 18). 
With this generation and persistence of potentially arthrito-
genic autoimmune Th17 cells in apparently nonarthritic ani-
mals, various extrinsic or intrinsic stimuli (e.g., exposure to 
physical, chemical, or biological agents that activate APCs, 
Figure 5.  Spontaneous development of autoimmune arthritis in 
IFN-𝗄–defi  cient SKG mice and IL-6–dependent cross-regulation 
between Th17 and Th1 cells. (A) Arthritis score in 6-mo-old cytokine-
defi  cient SKG mice under SPF conditions. (B) Histology of an ankle joint 
of a 6-mo-old SKG or IFN-γ−/− SKG mouse in A. (C) CD4+ T cells from 
wild-type, IFN-γ−/−, or IL-17−/− mice were transferred to RAG2−/− 
mice, which were i.v. injected with 1 mg anti–IL-6R mAb or control rat 
IgG twice (on the same day and day 3). Intracellular IL-17 and IFN-γ in 
recipient splenic CD4+ T cells were stained on day 7. (D) CD4+ T cells 
from BALB/c mice were transferred to RAG2−/− mice, which were i.v. 
treated with 1 mg anti–TGF-β and assessed as in C. (E) BALB/c CD4+ 
T cells nondepleted or depleted of CD4+CD25+ T cells were transferred 
to RAG2−/− mice and assessed as in C. Results in C–E represent three 
independent experiments.46  TH17 CELLS IN SPONTANEOUS AUTOIMMUNE ARTHRITIS | Hirota et al.
cause T lymphocytopenia, or alter cytokine milieu) may pre-
cipitate arthritis by further facilitating expansion/diff  erentia-
tion of arthritogenic Th17 cells.
The etiology of RA is largely obscure at present (19). Yet 
a genetically determined T cell anomaly might play a role in 
its pathogenesis in some RA patients, as suggested by recent 
fi  ndings that genetic polymorphism of a signaling molecule at 
a TCR proximal step signifi  cantly contributes to the suscep-
tibility to RA (20, 21). The polymorphism might contribute 
to thymic generation of potentially arthritogenic self-reactive 
T cells and their diff  erentiation to arthritogenic Th17 cells, as 
shown here with a mouse model of RA.
MATERIALS AND METHODS
Mice. BALB/c and BALB/c IFN-γ−/− mice were purchased from Japan 
Clea and The Jackson Laboratory, respectively. BALB/c IL-17−/− mice 
were described previously (10). IL-1−/−, IL-6−/−, or TNF-α−/− mice were 
backcrossed to BALB/c more than eight times and crossed to SKG mice to 
make cytokine-defi   cient SKG mice (3). RAG2−/− BALB/c mice were 
crossed to IL-6−/− mice to generate IL-6−/− RAG2−/− BALB/c mice. 
These mice were maintained in our animal facility and treated in accordance 
with the guidelines of Kyoto University.
Antibody. The following reagents were purchased from BD Biosciences: 
anti-CD3 (145-2C11), anti-CD4 (RM4-5), anti-CD16/CD32 (2.4G2), 
anti-CD25 (PC61), anti-CD40L (MR1), anti-CD45RB (16A), anti-BrdU 
(3D4), anti–TCR-αβ (H57-597), anti–IL-4 (11B11), anti–IL-10 (JESS-
16E3), anti–IFN-γ (XMG1.2), anti–TNF-α (MP6-XT22), anti–IL-17 
(TC11-18H10.1), and isotype control IgG. The following reagents were 
purchased from eBioscience: anti-CD44 (IM7), anti-CD69 (H1.2F3), anti–
RANK-L (1K22/5), anti-OX40 (OX-86), anti-OX40L (RM134L), and 
anti–IL-2 (JES6-5H4). Anti–class II MHC (CA4) and anti–TGF-β (1D11) 
were purifi  ed in our laboratory. Purifi  ed anti–IL-6R (MR16-1) was pro-
vided by N. Nishimoto (Osaka University, Osaka, Japan).
Intracellular cytokine staining. LN or spleen cells were stimulated 
with 20 ng/ml PMA and 1 μM ionomycin in the presence of Golgi-
Stop (BD Biosciences) for 5 h, and then stained with anti-CD4 or anti–
TCR-αβ and fi  xed and permeabilized using BD Cytofi  x/Cytoperm (BD 
Biosciences), followed by anti–IL-17 and anti–IFN-γ, TNF-α, IL-2, IL-4, 
or IL-10 staining.
In vivo BrdU labeling. Mice were i.p. injected with 1.0 mg BrdU (Sigma-
Aldrich) every 12 h twice and given 0.8 mg/ml BrdU in drinking water until 
cytofl  uorometric analysis.
Lymphocyte labeling with CFSE. HSA− CD4-SP thymocytes or CD4+ 
T cells were labeled with 3 μM CFSE (Dojindo).
AMLR. 2 × 104 HSA− CD4-SP thymocytes or CD4+ T cells were cul-
tured with 105 BALB/c splenic APCs, which were prepared by depleting 
Thy1.2+ cells by MACS (Miltenyi Biotec) in a 96-well round-bottom plate 
in complete RPMI medium. [3H]thymidine (1 μCi/well; Du Pont/New 
England Nuclear) was added during the last 12 h of culture.
Measurement of cytokines. IL-6 and TNF-α were measured by Cyto-
metric Bead Array (BD Biosciences), with the detection limits of 2 pg/ml for 
IL-6 and 7 pg/ml for TNF-α. IL-17 was measured by ELISA (R&D 
  Systems), with the detection limit of 11 pg/ml.
Statistical analysis. Student’s t test was used for statistical analyses. All 
p-values ≤0.05 were considered signifi  cant.
Online supplemental material. Fig. S1 shows IL-17 expression in 
BALB/c and SKG thymocytes assessed by RT-PCR and intracellular 
IL-17 staining. Fig. S2 shows percentages of IL-17+ or IFN-γ+ cells 
in individual RAG−/− mice transferred with CD4+ T cells and treated 
with anti–TGF-β mAb. Figs. S1 and S2 are available at http://www.jem
.org/cgi/content/full/jem.20062259/DC1.
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